Amplifold’s DNA Origami Tech Gets €5M to Supercharge Rapid Tests
A Munich biotech spin-off has secured €5 million in Seed funding to industrialize its DNA-origami platform. The tech aims to make standard lateral flow tests up to 100 times more sensitive without a major cost hike.